North America Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031
Published Date : 08-May-2024 |
Pages: 131 |
Formats: PDF |
COVID-19 Impact on the North America Drug Discovery Informatics Market
Market Overview
The North America Drug Discovery Informatics Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).
The US market dominated the North America Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,741.7 million by 2031. The Canada market is experiencing a CAGR of 12.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2024 - 2031).
By integrating data from multiple sources, including genomics, proteomics, transcriptomics, and metabolomics, informatics platforms enable researchers to comprehensively understand disease pathways, identify biomarkers, and prioritize potential drug targets for further investigation. Computational methods such as molecular modeling, virtual screening, and structure-activity relationship (SAR) analysis are pivotal in narrowing down vast chemical libraries to identify lead compounds with the greatest likelihood of success.
Furthermore, drug discovery informatics facilitates the assessment of pharmacokinetic and safety properties of lead compounds through in silico ADME-Tox prediction models, guiding compound selection and optimization early in the drug development process. These predictive tools help researchers identify potential risks and optimize compound structures to enhance efficacy, minimize toxicity, and improve overall drug candidate success rates.
In Mexico, cancer is a significant health concern, ranking as the third leading cause of death in the country. Over 195,000 new cancer cases were registered in 2020, with cervical, thyroid, colon, prostate, breast, and thyroid cancers being the most common. The nation reported 90,222 cancer-related fatalities in the same year, highlighting the urgent need for advancements in cancer treatment and drug discovery. The increasing incidence of cancer and the rising death rate from malignant tumors over the past decade underscore the importance of investing in drug discovery informatics to develop more effective and targeted therapies for cancer patients.
Mexico's National Council of Science and Technology (CONACYT) also plays a similar role in supporting R&D initiatives in healthcare, including those related to drug discovery informatics. CONACYT funds projects that contribute to Mexico's scientific and technological development, supporting innovation in the pharmaceutical industry. Hence, the market will expand rapidly in this region.
Free Valuable Insights: The Drug Discovery Informatics Market is Predict to reach USD 6.5 Billion by 2031, at a CAGR of 10.3%
Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Oracle Corporation
- Accenture PLC
- Thermo Fisher Scientific, Inc.
- Boehringer Ingelheim International GmbH
- Infosys Limited
- Charles River Laboratories International, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Certara, Inc.
- Jubilant Pharmova Limited
North America Drug Discovery Informatics Market Report Segmentation
By Application
- Drug Discovery
- Drug Development
By Function
- Sequencing & Target Data Analysis
- Molecular Modelling
- Library & Database Preparation
- Docking
- Others
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Drug Discovery Informatics Market, by Application
1.4.2 North America Drug Discovery Informatics Market, by Function
1.4.3 North America Drug Discovery Informatics Market, by End User
1.4.4 North America Drug Discovery Informatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Drug Discovery Informatics Market by Application
5.1 North America Drug Discovery Market by Country
5.2 North America Drug Development Market by Country
Chapter 6. North America Drug Discovery Informatics Market by Function
6.1 North America Sequencing & Target Data Analysis Market by Country
6.2 North America Molecular Modelling Market by Country
6.3 North America Library & Database Preparation Market by Country
6.4 North America Docking Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Drug Discovery Informatics Market by End User
7.1 North America Pharmaceutical Companies Market by Country
7.2 North America Biotechnology Companies Market by Country
7.3 North America Contract Research Organizations Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Drug Discovery Informatics Market by Country
8.1 US Drug Discovery Informatics Market
8.1.1 US Drug Discovery Informatics Market by Application
8.1.2 US Drug Discovery Informatics Market by Function
8.1.3 US Drug Discovery Informatics Market by End User
8.2 Canada Drug Discovery Informatics Market
8.2.1 Canada Drug Discovery Informatics Market by Application
8.2.2 Canada Drug Discovery Informatics Market by Function
8.2.3 Canada Drug Discovery Informatics Market by End User
8.3 Mexico Drug Discovery Informatics Market
8.3.1 Mexico Drug Discovery Informatics Market by Application
8.3.2 Mexico Drug Discovery Informatics Market by Function
8.3.3 Mexico Drug Discovery Informatics Market by End User
8.4 Rest of North America Drug Discovery Informatics Market
8.4.1 Rest of North America Drug Discovery Informatics Market by Application
8.4.2 Rest of North America Drug Discovery Informatics Market by Function
8.4.3 Rest of North America Drug Discovery Informatics Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Drug Discovery Informatics Market, by Application
1.4.2 North America Drug Discovery Informatics Market, by Function
1.4.3 North America Drug Discovery Informatics Market, by End User
1.4.4 North America Drug Discovery Informatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Drug Discovery Informatics Market by Application
5.1 North America Drug Discovery Market by Country
5.2 North America Drug Development Market by Country
Chapter 6. North America Drug Discovery Informatics Market by Function
6.1 North America Sequencing & Target Data Analysis Market by Country
6.2 North America Molecular Modelling Market by Country
6.3 North America Library & Database Preparation Market by Country
6.4 North America Docking Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Drug Discovery Informatics Market by End User
7.1 North America Pharmaceutical Companies Market by Country
7.2 North America Biotechnology Companies Market by Country
7.3 North America Contract Research Organizations Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Drug Discovery Informatics Market by Country
8.1 US Drug Discovery Informatics Market
8.1.1 US Drug Discovery Informatics Market by Application
8.1.2 US Drug Discovery Informatics Market by Function
8.1.3 US Drug Discovery Informatics Market by End User
8.2 Canada Drug Discovery Informatics Market
8.2.1 Canada Drug Discovery Informatics Market by Application
8.2.2 Canada Drug Discovery Informatics Market by Function
8.2.3 Canada Drug Discovery Informatics Market by End User
8.3 Mexico Drug Discovery Informatics Market
8.3.1 Mexico Drug Discovery Informatics Market by Application
8.3.2 Mexico Drug Discovery Informatics Market by Function
8.3.3 Mexico Drug Discovery Informatics Market by End User
8.4 Rest of North America Drug Discovery Informatics Market
8.4.1 Rest of North America Drug Discovery Informatics Market by Application
8.4.2 Rest of North America Drug Discovery Informatics Market by Function
8.4.3 Rest of North America Drug Discovery Informatics Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
List of Tables
TABLE 1 North America Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 2 North America Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Drug Discovery Informatics Market
TABLE 4 Product Launches And Product Expansions– Drug Discovery Informatics Market
TABLE 5 Acquisition and Mergers– Drug Discovery Informatics Market
TABLE 6 North America Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 7 North America Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 8 North America Drug Discovery Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Drug Discovery Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Drug Development Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Drug Development Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 13 North America Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 14 North America Sequencing & Target Data Analysis Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Sequencing & Target Data Analysis Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Molecular Modelling Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Molecular Modelling Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Library & Database Preparation Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Library & Database Preparation Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Docking Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Docking Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 25 North America Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 26 North America Pharmaceutical Companies Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Pharmaceutical Companies Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Contract Research Organizations Market by Country, 2020 - 2023, USD Million
TABLE 31 North America Contract Research Organizations Market by Country, 2024 - 2031, USD Million
TABLE 32 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Drug Discovery Informatics Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Drug Discovery Informatics Market by Country, 2024 - 2031, USD Million
TABLE 36 US Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 37 US Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 38 US Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 39 US Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 40 US Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 41 US Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 42 US Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 43 US Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 44 Canada Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 45 Canada Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 46 Canada Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 47 Canada Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 48 Canada Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 49 Canada Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 50 Canada Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 51 Canada Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 52 Mexico Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 53 Mexico Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 54 Mexico Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 55 Mexico Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 56 Mexico Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 57 Mexico Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 58 Mexico Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 59 Mexico Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 60 Rest of North America Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 61 Rest of North America Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 62 Rest of North America Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 63 Rest of North America Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 64 Rest of North America Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 65 Rest of North America Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 66 Rest of North America Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 67 Rest of North America Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 68 Key Information – Oracle Corporation
TABLE 69 Key Information – Accenture PLC
TABLE 70 Key Information – Thermo Fisher Scientific, Inc.
TABLE 71 Key Information – Boehringer Ingelheim International GmbH
TABLE 72 Key Information – Infosys Limited
TABLE 73 key information – Charles River Laboratories International, Inc.
TABLE 74 key Information – Agilent Technologies, Inc.
TABLE 75 key information – Illumina, Inc.
TABLE 76 Key Information – Certara, Inc.
TABLE 77 Key Information – Jubilant Pharmova Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Drug Discovery Informatics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Drug Discovery Informatics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis - Drug Discovery Informatics Market
FIG 8 North America Drug Discovery Informatics Market share by Application, 2023
FIG 9 North America Drug Discovery Informatics Market share by Application, 2031
FIG 10 North America Drug Discovery Informatics Market by Application, 2020 - 2031, USD Million
FIG 11 North America Drug Discovery Informatics Market share by Function, 2023
FIG 12 North America Drug Discovery Informatics Market share by Function, 2031
FIG 13 North America Drug Discovery Informatics Market by Function, 2020 - 2031, USD Million
FIG 14 North America Drug Discovery Informatics Market share by End User, 2023
FIG 15 North America Drug Discovery Informatics Market share by End User, 2031
FIG 16 North America Drug Discovery Informatics Market by End User, 2020 - 2031, USD Million
FIG 17 North America Drug Discovery Informatics Market share by Country, 2023
FIG 18 North America Drug Discovery Informatics Market share by Country, 2031
FIG 19 North America Drug Discovery Informatics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Oracle Corporation
FIG 21 SWOT Analysis: Accenture PLC
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Infosys Limited
FIG 26 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 27 Swot Analysis: Charles River Laboratories International, Inc.
FIG 28 Recent strategies and developments: Agilent Technologies, Inc.
FIG 29 Swot Analysis: Agilent Technologies, Inc.
FIG 30 Recent strategies and developments: Illumina, Inc.
FIG 31 Swot Analysis: Illumina, Inc.
FIG 32 Recent strategies and developments: Certara, Inc.
FIG 33 Swot Analysis: Certara, Inc.
FIG 34 Swot Analysis: Jubilant Pharmova Limited
TABLE 2 North America Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Drug Discovery Informatics Market
TABLE 4 Product Launches And Product Expansions– Drug Discovery Informatics Market
TABLE 5 Acquisition and Mergers– Drug Discovery Informatics Market
TABLE 6 North America Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 7 North America Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 8 North America Drug Discovery Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Drug Discovery Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Drug Development Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Drug Development Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 13 North America Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 14 North America Sequencing & Target Data Analysis Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Sequencing & Target Data Analysis Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Molecular Modelling Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Molecular Modelling Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Library & Database Preparation Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Library & Database Preparation Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Docking Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Docking Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 25 North America Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 26 North America Pharmaceutical Companies Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Pharmaceutical Companies Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Contract Research Organizations Market by Country, 2020 - 2023, USD Million
TABLE 31 North America Contract Research Organizations Market by Country, 2024 - 2031, USD Million
TABLE 32 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Drug Discovery Informatics Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Drug Discovery Informatics Market by Country, 2024 - 2031, USD Million
TABLE 36 US Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 37 US Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 38 US Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 39 US Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 40 US Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 41 US Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 42 US Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 43 US Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 44 Canada Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 45 Canada Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 46 Canada Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 47 Canada Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 48 Canada Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 49 Canada Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 50 Canada Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 51 Canada Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 52 Mexico Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 53 Mexico Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 54 Mexico Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 55 Mexico Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 56 Mexico Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 57 Mexico Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 58 Mexico Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 59 Mexico Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 60 Rest of North America Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 61 Rest of North America Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 62 Rest of North America Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 63 Rest of North America Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 64 Rest of North America Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 65 Rest of North America Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 66 Rest of North America Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 67 Rest of North America Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 68 Key Information – Oracle Corporation
TABLE 69 Key Information – Accenture PLC
TABLE 70 Key Information – Thermo Fisher Scientific, Inc.
TABLE 71 Key Information – Boehringer Ingelheim International GmbH
TABLE 72 Key Information – Infosys Limited
TABLE 73 key information – Charles River Laboratories International, Inc.
TABLE 74 key Information – Agilent Technologies, Inc.
TABLE 75 key information – Illumina, Inc.
TABLE 76 Key Information – Certara, Inc.
TABLE 77 Key Information – Jubilant Pharmova Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Drug Discovery Informatics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Drug Discovery Informatics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis - Drug Discovery Informatics Market
FIG 8 North America Drug Discovery Informatics Market share by Application, 2023
FIG 9 North America Drug Discovery Informatics Market share by Application, 2031
FIG 10 North America Drug Discovery Informatics Market by Application, 2020 - 2031, USD Million
FIG 11 North America Drug Discovery Informatics Market share by Function, 2023
FIG 12 North America Drug Discovery Informatics Market share by Function, 2031
FIG 13 North America Drug Discovery Informatics Market by Function, 2020 - 2031, USD Million
FIG 14 North America Drug Discovery Informatics Market share by End User, 2023
FIG 15 North America Drug Discovery Informatics Market share by End User, 2031
FIG 16 North America Drug Discovery Informatics Market by End User, 2020 - 2031, USD Million
FIG 17 North America Drug Discovery Informatics Market share by Country, 2023
FIG 18 North America Drug Discovery Informatics Market share by Country, 2031
FIG 19 North America Drug Discovery Informatics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Oracle Corporation
FIG 21 SWOT Analysis: Accenture PLC
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Infosys Limited
FIG 26 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 27 Swot Analysis: Charles River Laboratories International, Inc.
FIG 28 Recent strategies and developments: Agilent Technologies, Inc.
FIG 29 Swot Analysis: Agilent Technologies, Inc.
FIG 30 Recent strategies and developments: Illumina, Inc.
FIG 31 Swot Analysis: Illumina, Inc.
FIG 32 Recent strategies and developments: Certara, Inc.
FIG 33 Swot Analysis: Certara, Inc.
FIG 34 Swot Analysis: Jubilant Pharmova Limited